Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Angion Biomedica Corp
(NQ:
ANGN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Angion Biomedica Corp
< Previous
1
2
3
Next >
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
June 30, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical...
Via
Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
June 30, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Angion Biomedica Pulls The Plug On Another Kidney Disease Trial - Read Why
June 30, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022
June 30, 2022
Upgrades
Via
Benzinga
Angion Biomedica's Return On Capital Employed Overview
June 22, 2022
Benzinga Pro data, Angion Biomedica (NASDAQ:ANGN) reported Q1 sales of $1.65 million. Earnings fell to a loss of $14.24 million, resulting in a 195.63% decrease from last quarter.
Via
Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
June 23, 2022
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Via
Benzinga
Angion Biomedica: Q1 Earnings Insights
May 16, 2022
Angion Biomedica (NASDAQ:ANGN) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
79 Biggest Movers From Yesterday
June 08, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's pūrgo technology, classifying it...
Via
Benzinga
Angion Biomedica Is 'Better Positioned' Than Peers Despite Trial Failure, HC Wainwright Thinks So
April 18, 2022
Via
Benzinga
77 Biggest Movers From Yesterday
June 01, 2022
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate...
Via
Benzinga
Angion Biomedica's Return On Capital Employed Insights
March 31, 2022
According to Benzinga Pro, during Q4, Angion Biomedica (NASDAQ:ANGN) earned $14.89 million, a 194.82% increase from the preceding quarter. Angion Biomedica also posted a total of $25.94 million in...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 02, 2022
Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by...
Via
Benzinga
52 Biggest Movers From Friday
January 31, 2022
Gainers Knightscope, Inc. (NASDAQ: KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at $10 per share. Imperial Petroleum Inc. (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
January 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,...
Via
Benzinga
63 Biggest Movers From Yesterday
December 31, 2021
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its...
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
December 30, 2021
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors. Future...
Via
Benzinga
50 Biggest Movers From Friday
December 13, 2021
Gainers SigmaTron International, Inc. (NASDAQ: SGMA) jumped 84.7% to settle at $14.94 on Friday after the company reported Q2 EPS and sales results were higher year over year....
Via
Benzinga
Mid-Afternoon Market Update: Dow Rises 150 Points; SigmaTron International Shares Spike Higher
December 10, 2021
Toward the end of trading Friday, the Dow traded up 0.42% to 35,905.44 while the NASDAQ rose 0.34% to 15,570.02. The S&P also rose, gaining 0.66% to 4,698.21. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
36 Stocks Moving In Friday's Mid-Day Session
December 10, 2021
Gainers American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) jumped 43.1% to $2.6909. American Virtual Cloud Technologies shares jumped over 82% on Thursday after the company...
Via
Benzinga
Mid-Day Market Update: Oracle Gains Following Upbeat Q2 Results; Angion Biomedica Shares Drop
December 10, 2021
Midway through trading Friday, the Dow traded up 0.09% to 35,787.47 while the NASDAQ rose 0.11% to 15,534.76. The S&P also rose, gaining 0.38% to 4,685.15. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Mid-Morning Market Update: Markets Open Higher; Inflation Rate Increases To 6.8%
December 10, 2021
Following the market opening Friday, the Dow traded up 0.48% to 35,924.79 while the NASDAQ rose 0.47% to 15,579.93. The S&P also rose, gaining 0.60% to 4,695.55. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
December 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Angion Biomedica's ANG-3777 Does Not Meet Primary Endpoint In Mid-Stage...
Via
Benzinga
Angion's ANG-3777 Faces Third Failure In 2021, This Time Flunks Acute Kidney Injury Trial
December 10, 2021
Angion Biomedica Corp (NASDAQ: ANGN) and Vifor Pharma shared results from the Phase 2 GUARD trial of Angion's ANG-3777 in cardiac surgery patients with...
Via
Benzinga
Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
December 10, 2021
From
Vifor Pharma
Via
Business Wire
Mid-Afternoon Market Update: Nasdaq Surges Over 100 Points; Cortexyme Shares Plunge
October 27, 2021
Toward the end of trading Wednesday, the Dow traded down 0.23% to 35,674.01 while the NASDAQ rose 0.81% to 15,358.79. The S&P also rose, gaining 0.14% to 4,581.2. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
64 Biggest Movers From Yesterday
October 28, 2021
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...
Via
Benzinga
Mid-Day Market Update: Dow Falls Over 100 Points; Silicon Laboratories Shares Spike Higher
October 27, 2021
Midway through trading Wednesday, the Dow traded down 0.30% to 35,648.39 while the NASDAQ rose 0.32% to 15,283.97. The S&P also fell, dropping 0.03% to 4,573.51. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Did Angion Biomedica's Shares tumble Premarket Today?
October 27, 2021
After flopping a test in COVID-19 earlier this year, Angion Biomedica Corp's (NASDAQ: ANGN) lead candidate drug has hit a setback again, this time in kidney...
Via
Benzinga
Exposures
COVID-19
28 Stocks Moving in Wednesday's Pre-Market Session
October 27, 2021
Gainers China XD Plastics Company Limited (NASDAQ: CXDC) rose 139% to $1.40 in pre-market trading after jumping around 30% on Tuesday. Guardion Health Sciences, Inc. (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.